STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA: What Influences Acute Rejection Episode and Long-Term Graft Survival?
During the past 5-year period from 1986 to 1991, a total of 54 patients received living-related renal allograft and has been managed with vagaries of cyclosporin A (CYA) immunosuppressive regimen. In order to determine the ideal form of induction regimen, combination drugs with CYA, the initial dosa...
Gespeichert in:
| Veröffentlicht in: | Nippon Hinyokika Gakkai zasshi 1992/12/20, Vol.83(12), pp.1970-1977 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1977 |
|---|---|
| container_issue | 12 |
| container_start_page | 1970 |
| container_title | Nippon Hinyokika Gakkai zasshi |
| container_volume | 83 |
| creator | Tanda, Katsutoshi Togashi, Masaki Takeuchi, Ichiro Chikaraishi, Tatsuya Koyanagi, Tomohiko Kanagawa, Kouichi Hirano, Tetsuo Seki, Toshimori Tsubo, Syunsuke |
| description | During the past 5-year period from 1986 to 1991, a total of 54 patients received living-related renal allograft and has been managed with vagaries of cyclosporin A (CYA) immunosuppressive regimen. In order to determine the ideal form of induction regimen, combination drugs with CYA, the initial dosage of CYA and its blood trough level were retrospectively analyzed with particular reference to the possible factors relevant to the occurrence of acute rejection episode in the first three post-transplant months and graft survival. The combination drugs with CYA were predonisolone (PRD) in 10 patients, PRD+azathioprine (AZA) in 19 and PRD+mizoribine (MIZ) in 25. The initial dosage of CYA was 6mg/kg B. W. in 6 patients, 8mg/kg in 17, 10mg/kg in 15 and ≥12mg/kg in 16. Blood trough level of CYA measured principally by high performance liquid chromatography was arbitrarily divided into 200mg/kg ranges for the analysis. By arbitrarily dividing the post-transplant period into four (period I: 0-15th day, period II: 16-30th, period III: 31-60th and period IV: 61-90th), the correlation of the incidence of acute rejection episode and aforementioned factors was studied. Relevance of these factors to the graft survival was also studied. The administration of AZA to MIZ to CYA+PRD had no suppressive effect upon the occurrence of acute rejection during the first three months and similarly it had no effect upon graft survival. Rejection episodes, however, occurred more frequently in the recipients with less than 150ng/ml of CYA trough level in the period I and less than 100ng/ml in the period III (p |
| doi_str_mv | 10.5980/jpnjurol1989.83.1970 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73430552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73430552</sourcerecordid><originalsourceid>FETCH-LOGICAL-j189t-7f0bd130485cc82bd88f267410bd8f18632a0e868a646ed2da3901d53a9a9e5e3</originalsourceid><addsrcrecordid>eNpNkEtrg1AQhS-lJQ1p_kELrrozvU_vuCpiTSOVGIxZZCVXvbaKedTHov--lkjoZoYz3-HAHIQeCV4IG_BLdT5WfXOqiQ32AtiC2BLfoCkB4KYkBN-iKcaUmIKCvEfzti1TzIgECoxN0IRwySXmU_S6jXdveyNcGoIbkbd2AsMJgvA9cpbxoF1_43vreGv4ayNeeYa7d4NwuwmjQTuGFzkP6K5Qdavn456h3dKL3ZU5ZPiuE5gVAbszZYHTnDDMQWQZ0DQHKKglORnOUBCwGFVYgwXK4pbOaa6YjUkumLKVrYVmM_R8yT03p-9et11yKNtM17U66lPfJpJxhoWgg_FpNPbpQefJuSkPqvlJxo8H_nHhVdupT33lqunKrNbJ_2ITYAmh4_xr-OrKvlST6CP7BZPIboI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73430552</pqid></control><display><type>article</type><title>STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA: What Influences Acute Rejection Episode and Long-Term Graft Survival?</title><source>MEDLINE</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Tanda, Katsutoshi ; Togashi, Masaki ; Takeuchi, Ichiro ; Chikaraishi, Tatsuya ; Koyanagi, Tomohiko ; Kanagawa, Kouichi ; Hirano, Tetsuo ; Seki, Toshimori ; Tsubo, Syunsuke</creator><creatorcontrib>Tanda, Katsutoshi ; Togashi, Masaki ; Takeuchi, Ichiro ; Chikaraishi, Tatsuya ; Koyanagi, Tomohiko ; Kanagawa, Kouichi ; Hirano, Tetsuo ; Seki, Toshimori ; Tsubo, Syunsuke</creatorcontrib><description>During the past 5-year period from 1986 to 1991, a total of 54 patients received living-related renal allograft and has been managed with vagaries of cyclosporin A (CYA) immunosuppressive regimen. In order to determine the ideal form of induction regimen, combination drugs with CYA, the initial dosage of CYA and its blood trough level were retrospectively analyzed with particular reference to the possible factors relevant to the occurrence of acute rejection episode in the first three post-transplant months and graft survival. The combination drugs with CYA were predonisolone (PRD) in 10 patients, PRD+azathioprine (AZA) in 19 and PRD+mizoribine (MIZ) in 25. The initial dosage of CYA was 6mg/kg B. W. in 6 patients, 8mg/kg in 17, 10mg/kg in 15 and ≥12mg/kg in 16. Blood trough level of CYA measured principally by high performance liquid chromatography was arbitrarily divided into <100, 100-150, 150-200, >200mg/kg ranges for the analysis. By arbitrarily dividing the post-transplant period into four (period I: 0-15th day, period II: 16-30th, period III: 31-60th and period IV: 61-90th), the correlation of the incidence of acute rejection episode and aforementioned factors was studied. Relevance of these factors to the graft survival was also studied. The administration of AZA to MIZ to CYA+PRD had no suppressive effect upon the occurrence of acute rejection during the first three months and similarly it had no effect upon graft survival. Rejection episodes, however, occurred more frequently in the recipients with less than 150ng/ml of CYA trough level in the period I and less than 100ng/ml in the period III (p<0.01). Five-year graft survival rate of those patients whose blood trough level was adequately maintained at ≥150ng/ml in the period I and ≥100ng/ml in the period III was significantly better than that of the others whose trough level was inadequate with <150ng/ml in the period I and/or <100ng/ml in the period III (89 percent vs 61 percent, respectively. p<0.05). We concluded that blood trough level of CYA should be maintained optimally at ≥150ng/ml in the period I and ≥100ng/ml in the period III as these are the only factors relevant to acute rejection episodes in the first three post-transplant months and subsequent graft survival.</description><identifier>ISSN: 0021-5287</identifier><identifier>EISSN: 1884-7110</identifier><identifier>DOI: 10.5980/jpnjurol1989.83.1970</identifier><identifier>PMID: 1474704</identifier><language>jpn</language><publisher>Japan: THE JAPANESE UROLOGICAL ASSOCIATION</publisher><subject>acute rejection ; Adolescent ; Adult ; Azathioprine - administration & dosage ; Child, Preschool ; cyclosporin A ; Cyclosporine - administration & dosage ; Cyclosporine - therapeutic use ; Female ; Graft Rejection - immunology ; Graft Survival - drug effects ; Humans ; Kidney Transplantation - immunology ; Male ; Middle Aged ; Prednisolone - administration & dosage ; Prognosis ; renal transplant ; Retrospective Studies ; Ribonucleosides - administration & dosage</subject><ispartof>The Japanese Journal of Urology, 1992/12/20, Vol.83(12), pp.1970-1977</ispartof><rights>Japanese Urological Association</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1474704$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanda, Katsutoshi</creatorcontrib><creatorcontrib>Togashi, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Ichiro</creatorcontrib><creatorcontrib>Chikaraishi, Tatsuya</creatorcontrib><creatorcontrib>Koyanagi, Tomohiko</creatorcontrib><creatorcontrib>Kanagawa, Kouichi</creatorcontrib><creatorcontrib>Hirano, Tetsuo</creatorcontrib><creatorcontrib>Seki, Toshimori</creatorcontrib><creatorcontrib>Tsubo, Syunsuke</creatorcontrib><title>STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA: What Influences Acute Rejection Episode and Long-Term Graft Survival?</title><title>Nippon Hinyokika Gakkai zasshi</title><addtitle>Jpn. j. urol</addtitle><description>During the past 5-year period from 1986 to 1991, a total of 54 patients received living-related renal allograft and has been managed with vagaries of cyclosporin A (CYA) immunosuppressive regimen. In order to determine the ideal form of induction regimen, combination drugs with CYA, the initial dosage of CYA and its blood trough level were retrospectively analyzed with particular reference to the possible factors relevant to the occurrence of acute rejection episode in the first three post-transplant months and graft survival. The combination drugs with CYA were predonisolone (PRD) in 10 patients, PRD+azathioprine (AZA) in 19 and PRD+mizoribine (MIZ) in 25. The initial dosage of CYA was 6mg/kg B. W. in 6 patients, 8mg/kg in 17, 10mg/kg in 15 and ≥12mg/kg in 16. Blood trough level of CYA measured principally by high performance liquid chromatography was arbitrarily divided into <100, 100-150, 150-200, >200mg/kg ranges for the analysis. By arbitrarily dividing the post-transplant period into four (period I: 0-15th day, period II: 16-30th, period III: 31-60th and period IV: 61-90th), the correlation of the incidence of acute rejection episode and aforementioned factors was studied. Relevance of these factors to the graft survival was also studied. The administration of AZA to MIZ to CYA+PRD had no suppressive effect upon the occurrence of acute rejection during the first three months and similarly it had no effect upon graft survival. Rejection episodes, however, occurred more frequently in the recipients with less than 150ng/ml of CYA trough level in the period I and less than 100ng/ml in the period III (p<0.01). Five-year graft survival rate of those patients whose blood trough level was adequately maintained at ≥150ng/ml in the period I and ≥100ng/ml in the period III was significantly better than that of the others whose trough level was inadequate with <150ng/ml in the period I and/or <100ng/ml in the period III (89 percent vs 61 percent, respectively. p<0.05). We concluded that blood trough level of CYA should be maintained optimally at ≥150ng/ml in the period I and ≥100ng/ml in the period III as these are the only factors relevant to acute rejection episodes in the first three post-transplant months and subsequent graft survival.</description><subject>acute rejection</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Azathioprine - administration & dosage</subject><subject>Child, Preschool</subject><subject>cyclosporin A</subject><subject>Cyclosporine - administration & dosage</subject><subject>Cyclosporine - therapeutic use</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Survival - drug effects</subject><subject>Humans</subject><subject>Kidney Transplantation - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prednisolone - administration & dosage</subject><subject>Prognosis</subject><subject>renal transplant</subject><subject>Retrospective Studies</subject><subject>Ribonucleosides - administration & dosage</subject><issn>0021-5287</issn><issn>1884-7110</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtrg1AQhS-lJQ1p_kELrrozvU_vuCpiTSOVGIxZZCVXvbaKedTHov--lkjoZoYz3-HAHIQeCV4IG_BLdT5WfXOqiQ32AtiC2BLfoCkB4KYkBN-iKcaUmIKCvEfzti1TzIgECoxN0IRwySXmU_S6jXdveyNcGoIbkbd2AsMJgvA9cpbxoF1_43vreGv4ayNeeYa7d4NwuwmjQTuGFzkP6K5Qdavn456h3dKL3ZU5ZPiuE5gVAbszZYHTnDDMQWQZ0DQHKKglORnOUBCwGFVYgwXK4pbOaa6YjUkumLKVrYVmM_R8yT03p-9et11yKNtM17U66lPfJpJxhoWgg_FpNPbpQefJuSkPqvlJxo8H_nHhVdupT33lqunKrNbJ_2ITYAmh4_xr-OrKvlST6CP7BZPIboI</recordid><startdate>199212</startdate><enddate>199212</enddate><creator>Tanda, Katsutoshi</creator><creator>Togashi, Masaki</creator><creator>Takeuchi, Ichiro</creator><creator>Chikaraishi, Tatsuya</creator><creator>Koyanagi, Tomohiko</creator><creator>Kanagawa, Kouichi</creator><creator>Hirano, Tetsuo</creator><creator>Seki, Toshimori</creator><creator>Tsubo, Syunsuke</creator><general>THE JAPANESE UROLOGICAL ASSOCIATION</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199212</creationdate><title>STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA</title><author>Tanda, Katsutoshi ; Togashi, Masaki ; Takeuchi, Ichiro ; Chikaraishi, Tatsuya ; Koyanagi, Tomohiko ; Kanagawa, Kouichi ; Hirano, Tetsuo ; Seki, Toshimori ; Tsubo, Syunsuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j189t-7f0bd130485cc82bd88f267410bd8f18632a0e868a646ed2da3901d53a9a9e5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1992</creationdate><topic>acute rejection</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Azathioprine - administration & dosage</topic><topic>Child, Preschool</topic><topic>cyclosporin A</topic><topic>Cyclosporine - administration & dosage</topic><topic>Cyclosporine - therapeutic use</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Survival - drug effects</topic><topic>Humans</topic><topic>Kidney Transplantation - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prednisolone - administration & dosage</topic><topic>Prognosis</topic><topic>renal transplant</topic><topic>Retrospective Studies</topic><topic>Ribonucleosides - administration & dosage</topic><toplevel>online_resources</toplevel><creatorcontrib>Tanda, Katsutoshi</creatorcontrib><creatorcontrib>Togashi, Masaki</creatorcontrib><creatorcontrib>Takeuchi, Ichiro</creatorcontrib><creatorcontrib>Chikaraishi, Tatsuya</creatorcontrib><creatorcontrib>Koyanagi, Tomohiko</creatorcontrib><creatorcontrib>Kanagawa, Kouichi</creatorcontrib><creatorcontrib>Hirano, Tetsuo</creatorcontrib><creatorcontrib>Seki, Toshimori</creatorcontrib><creatorcontrib>Tsubo, Syunsuke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Nippon Hinyokika Gakkai zasshi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanda, Katsutoshi</au><au>Togashi, Masaki</au><au>Takeuchi, Ichiro</au><au>Chikaraishi, Tatsuya</au><au>Koyanagi, Tomohiko</au><au>Kanagawa, Kouichi</au><au>Hirano, Tetsuo</au><au>Seki, Toshimori</au><au>Tsubo, Syunsuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA: What Influences Acute Rejection Episode and Long-Term Graft Survival?</atitle><jtitle>Nippon Hinyokika Gakkai zasshi</jtitle><addtitle>Jpn. j. urol</addtitle><date>1992-12</date><risdate>1992</risdate><volume>83</volume><issue>12</issue><spage>1970</spage><epage>1977</epage><pages>1970-1977</pages><issn>0021-5287</issn><eissn>1884-7110</eissn><abstract>During the past 5-year period from 1986 to 1991, a total of 54 patients received living-related renal allograft and has been managed with vagaries of cyclosporin A (CYA) immunosuppressive regimen. In order to determine the ideal form of induction regimen, combination drugs with CYA, the initial dosage of CYA and its blood trough level were retrospectively analyzed with particular reference to the possible factors relevant to the occurrence of acute rejection episode in the first three post-transplant months and graft survival. The combination drugs with CYA were predonisolone (PRD) in 10 patients, PRD+azathioprine (AZA) in 19 and PRD+mizoribine (MIZ) in 25. The initial dosage of CYA was 6mg/kg B. W. in 6 patients, 8mg/kg in 17, 10mg/kg in 15 and ≥12mg/kg in 16. Blood trough level of CYA measured principally by high performance liquid chromatography was arbitrarily divided into <100, 100-150, 150-200, >200mg/kg ranges for the analysis. By arbitrarily dividing the post-transplant period into four (period I: 0-15th day, period II: 16-30th, period III: 31-60th and period IV: 61-90th), the correlation of the incidence of acute rejection episode and aforementioned factors was studied. Relevance of these factors to the graft survival was also studied. The administration of AZA to MIZ to CYA+PRD had no suppressive effect upon the occurrence of acute rejection during the first three months and similarly it had no effect upon graft survival. Rejection episodes, however, occurred more frequently in the recipients with less than 150ng/ml of CYA trough level in the period I and less than 100ng/ml in the period III (p<0.01). Five-year graft survival rate of those patients whose blood trough level was adequately maintained at ≥150ng/ml in the period I and ≥100ng/ml in the period III was significantly better than that of the others whose trough level was inadequate with <150ng/ml in the period I and/or <100ng/ml in the period III (89 percent vs 61 percent, respectively. p<0.05). We concluded that blood trough level of CYA should be maintained optimally at ≥150ng/ml in the period I and ≥100ng/ml in the period III as these are the only factors relevant to acute rejection episodes in the first three post-transplant months and subsequent graft survival.</abstract><cop>Japan</cop><pub>THE JAPANESE UROLOGICAL ASSOCIATION</pub><pmid>1474704</pmid><doi>10.5980/jpnjurol1989.83.1970</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0021-5287 |
| ispartof | The Japanese Journal of Urology, 1992/12/20, Vol.83(12), pp.1970-1977 |
| issn | 0021-5287 1884-7110 |
| language | jpn |
| recordid | cdi_proquest_miscellaneous_73430552 |
| source | MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | acute rejection Adolescent Adult Azathioprine - administration & dosage Child, Preschool cyclosporin A Cyclosporine - administration & dosage Cyclosporine - therapeutic use Female Graft Rejection - immunology Graft Survival - drug effects Humans Kidney Transplantation - immunology Male Middle Aged Prednisolone - administration & dosage Prognosis renal transplant Retrospective Studies Ribonucleosides - administration & dosage |
| title | STUDY OF 54 RENAL ALLOGRAFT RECIPIENTS IN THE CYCLOSPORIN A ERA: What Influences Acute Rejection Episode and Long-Term Graft Survival? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T02%3A26%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=STUDY%20OF%2054%20RENAL%20ALLOGRAFT%20RECIPIENTS%20IN%20THE%20CYCLOSPORIN%20A%20ERA:%20What%20Influences%20Acute%20Rejection%20Episode%20and%20Long-Term%20Graft%20Survival?&rft.jtitle=Nippon%20Hinyokika%20Gakkai%20zasshi&rft.au=Tanda,%20Katsutoshi&rft.date=1992-12&rft.volume=83&rft.issue=12&rft.spage=1970&rft.epage=1977&rft.pages=1970-1977&rft.issn=0021-5287&rft.eissn=1884-7110&rft_id=info:doi/10.5980/jpnjurol1989.83.1970&rft_dat=%3Cproquest_pubme%3E73430552%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73430552&rft_id=info:pmid/1474704&rfr_iscdi=true |